‘INVESTING IN US-BASED MANUFACTURING FACILITY’

“As we look ahead, we are investing and adding to our discovery footprint both in Hyderabad and Bengaluru, as our customers’ discovery needs are growing rapidly. In development and manufacturing, we recently invested significantly in expansions, and now have the capacity to meet our customers’ near and long-term future needs. In Biologics, we are advancing downstream capabilities, and investing in a manufacturing facility in the US to offer a single seamless solution to our customers who want to develop and manufacture from a single site.” - MANNI KANTIPUDI, Chief Executive Officer, Aragen Life Sciences, Hyderabad